1. Home
  2. BGSF vs ATNM Comparison

BGSF vs ATNM Comparison

Compare BGSF & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$4.46

Market Cap

49.1M

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.45

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSF
ATNM
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
50.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGSF
ATNM
Price
$4.46
$1.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$4.00
AVG Volume (30 Days)
67.9K
206.2K
Earning Date
11-07-2025
11-14-2025
Dividend Yield
44.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$263,687,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
71.60
11.11
52 Week Low
$2.91
$1.03
52 Week High
$8.22
$2.41

Technical Indicators

Market Signals
Indicator
BGSF
ATNM
Relative Strength Index (RSI) 59.36 54.26
Support Level $4.29 $1.33
Resistance Level $4.76 $1.48
Average True Range (ATR) 0.22 0.11
MACD 0.08 0.02
Stochastic Oscillator 69.57 58.90

Price Performance

Historical Comparison
BGSF
ATNM

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: